Heroin Facts
Opioid;
Description
Heroin (diacetylmorphine) — smack, junk, dope — is a semi-synthetic opioid of the morphinan class. It activates opioid receptors, suppressing pain signals and depressing the brainstem's drive to breathe.[1]
Subjective effects include profound pain suppression, euphoria, heavy sedation, anxiolysis, and a warm enveloping calm. The experience is defined by its onset — intravenous use produces a rapid, overwhelming wave of warmth that erases pain and distress, distinguishing it from the slower build of morphine.
Heroin produces rapid physical dependence and has the narrowest safety margin of any commonly used substance.[2] Tolerance to euphoria develops faster than tolerance to respiratory depression,[3] so dose escalation closes the gap between intoxication and fatal overdose; mortality among untreated dependent people reaches 36.1 per 1000 person-years.[4]
Dose and durationby route · individual sensitivity varies
Starts in 0.08 – 0.17 minLasts 3 – 5 hoursAfter-effects 1 – 3 hours
Body and dependence
- Acute toxicity
- Critical
- Chronic toxicity
- High
- Physical dependence
- High
- Psychological dependence
- High
- Withdrawal
- Severe · medical supervision
- Compulsive redosing
- High
Tolerance
- Builds
- Rapid
- Fully resets after
- 10 days
- Carries over to
- morphine;
oxycodone; fentanyl; methadone; hydromorphone; codeine; buprenorphine
Effectslikely at a common dose
- Perception
- Sleep-transition hallucinations;
+5 possible, including Spatial disorientation, Visual acuity suppression - Body
- Sedation;
Tactile euphoria; Pain suppression; Constipation; Pupil constriction; Bodily heaviness; Body high; Breathing alteration; Muscle relaxation; Physical fatigue; +15 possible, including Respiratory depression, Nausea, Motor control impairment - Thinking
- Compulsive redosing urge;
Cognitive euphoria; Cognitive fatigue; Cognitive impairment; Information processing suppression; Thought deceleration; +11 possible, including Decision impairment, Analysis suppression, Language suppression - Feeling
- Anxiety suppression;
Euphoria; +1 possible - Self
- Craving;
+4 possible, including Communication suppression, Social disconnection - Time
- none likely · 3 possible, including Temporal disorientation
Who shouldn't take it
Combinations62 recorded
Seek help immediately if
- Unresponsive / can't be woken, even to a firm sternal rub
- Slow, shallow, or stopped breathing
- Pinpoint pupils
- Blue/grey lips, fingertips, or skin (cyanosis)
- Limp body; pale, clammy skin
- Choking or gurgling sounds ("death rattle")
- Slow, erratic, or absent pulse
What to do
- Try to wake them — shout their name, firm sternal rub
- Call emergency services immediately
- Administer naloxone if available
- Give rescue breaths (or CPR if there is no pulse)
- Place them in the recovery position
- Stay with them; re-dose naloxone every 2–3 minutes if there is no response
- Reversal agent
- Naloxone (Narcan) — opioid antagonist. May require repeated doses; its effect can wear off before the opioid does.
With prompt naloxone and rescue breathing, reversal is usually rapid. Because naloxone can wear off before the opioid — especially with long-acting opioids (methadone) or high-potency ones (fentanyl) — a period of monitoring is needed even after the person revives.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Milella MS, D'Ottavio G, De Pirro S, Barra M, Caprioli D, Badiani A (2023) Heroin and its metabolites: relevance to heroin use disorder — Translational Psychiatry doi:10.1038/s41398-023-02406-5
- [2]^Lachenmeier DW, Rehm J (2015) Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach — Scientific Reports doi:10.1038/srep08126
- [3]^Sim-Selley LJ, Selley DE, Vogt LJ, et al. (2000) Chronic Heroin Self-Administration Desensitizes mu Opioid Receptor-Activated G-Proteins in Specific Regions of Rat Brain — Journal of Neuroscience doi:10.1523/jneurosci.20-12-04555.2000
- [4]^Sordo L, Barrio G, Bravo MJ, et al. (2017) Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies — BMJ doi:10.1136/bmj.j1550